For patients with a first unprovoked venous thromboembolism (VTE), indefinite anticoagulation prevents some recurrent VTE events but induces additional major bleeding events, according to a study published online June 27 ...
Jun 29, 2023
0
0
Implantable devices and wearables like smart-watches enable continuous or near-continuous monitoring of cardiac rhythm. This leads to detection of short arrhythmias in many people, especially elderly persons with cardiovascular ...
Jun 28, 2023
0
4
A cohort study of more than 90,000 older adults diagnosed with atrial fibrillation (Afib) who were treated with anticoagulants found that treatment with amiodarone during apixaban or rivaroxaban use was associated with greater ...
May 22, 2023
0
2
The risk of new thromboembolic events after discontinuation of anticoagulant therapy in patients with pulmonary embolism or deep vein thrombosis associated with COVID-19 is low and similar to that of patients with venous ...
May 3, 2023
0
6
A region-wide study in more than 50,000 patients with atrial fibrillation has found reduced risks of stroke and transient ischemic attack in those who started statins within a year of diagnosis compared with those who did ...
Apr 17, 2023
0
52
High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is low-dose anticoagulation. ...
Mar 6, 2023
0
8
A cost-effectiveness analysis comparing direct oral anticoagulants (DOACs) to low-molecular-weight heparin (LMWH) found that DOACs are both more medically effective and cost-effective than LMWH when treating cancer-associated ...
Dec 26, 2022
0
18
The AustralaSian COVID-19 Trial (ASCOT) has pinpointed the most efficient level of blood thinning treatment needed for patients hospitalized with COVID-19, in a study published in the New England Journal of Medicine Evidence ...
Dec 11, 2022
0
20
Black patients with atrial fibrillation are less likely to be prescribed newer anticoagulant medications when they leave the hospital compared to their white counterparts and are consequently more likely to experience adverse ...
Oct 27, 2022
0
58
Heart disease patients with symptomatic COVID-19 are often treated with nirmatrelvir-ritonavir (Paxlovid) to prevent progression to severe disease; however, it can interact with some previously prescribed medications. A review ...
Oct 12, 2022
0
15
